Clinical Trial Update: A Clinical Study Evaluating the Safety and Efficacy of SKG0106 in Patients With Neovascular Age-related Macular Degeneration (nAMD) [Phase 1]

View source ↗

Summary

A Phase 1 clinical study evaluating the safety and efficacy of SKG0106 for neovascular age-related macular degeneration is currently recruiting. The sponsor is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• SKG0106

Snippet

Sponsor: Youxin Chen | Conditions: Neovascular Age-related Macular Degeneration | Phase 1 | Status: RECRUITING